Marrian Medical Technologies

Technology

One Platform. Two Tracks.

Marrian Medical Technologies is building an integrated wound-care platform. A therapy system designed to accelerate healing, and an intelligence layer that measures whether it's working.

Each track stands on its own. Together, they produce a dataset no image-only competitor can build.

Track 01 · Therapy System

VacuVolt

An integrated wound-care therapy device combining an innovative negative pressure methodology with another novel healing modality within a single coordinated platform. Advanced in partnership with the University of Hawaii and the original inventors.

  • Integrated wound-care therapy device advanced with the University of Hawaii and the original inventors
  • Combines an innovative negative pressure methodology with another novel healing modality (specifics confidential)
  • Department of War transition pathway; anticipated Class II 510(k) regulatory route

Designed to accelerate wound closure; efficacy under preclinical investigation. No clearance obtained.

Track 02 · Intelligence Layer

Wound Intelligence

An edge-deployed computer vision and predictive analytics system that quantifies wound response. Wound Intelligence translates visual healing characteristics and therapy telemetry into structured data — the signal of whether treatment is working.

  • Edge-deployed computer vision for wound imaging: normalization, morphological edge-detection, tissue segmentation
  • Predictive analytics that translate imaging + adherence + therapy telemetry into a structured signal of healing progress
  • Software-as-a-Medical-Device (SaMD) pathway; tuned for high recall to surface stalling wounds and early infection markers

Software in development. No clearance obtained.

Why Both Live in One Company

The Fusion No Image-Only Competitor Can Build

Every AI wound-care company analyzes images. None own a therapy device. Owning both halves is the only way to fuse imaging with real therapy telemetry — pressure levels, seal failures, stim dose, adherence — against healing outcomes.

Read the full "Why Both" thesis

Interested in the Platform?

Marrian welcomes inquiries from qualified research institutions, medical-device organizations, clinical collaborators, government stakeholders, investors, and strategic partners.

Start a Conversation